← FDA Drug Approvals (Drugs@FDA)
PHYRAGO
NDA · New Drug Application · Sponsor: HANDA THERAP · Approved 2023-12-05
Drug application
- FDA Application #
NDA216099- Application type
- New Drug Application
- Brand name
- PHYRAGO
- Generic name
- DASATINIB
- Active ingredients
- DASATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HANDA THERAP
- Manufacturer
- Cycle Pharmaceuticals Ltd
- First approval
- 2023-12-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown